Skip to content
Channels - Comparative Cancer Incidence by Organ Site in Rheumatoid Arthritis Treated with Janus Kinase Inhibitors versus Tumor Necrosis Factor Inhibitors: A Retrospective Real-World Cohort Analysis :: FRELIP Discovery
Channels
Comparative Cancer Incidence by Organ Site in Rheumatoid Arthritis Treated with Janus Kinase Inhibitors versus Tumor Necrosis Factor Inhibitors: A Retrospective Real-World Cohort Analysis
Janus Kinase Inhibitors for Treatment of Palmoplantar Pustulosis, Generalized Pustular Psoriasis, and Palmoplantar Pustular Psoriasis: A Systematic Review of the Literature
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk
Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
Rheumatoid arthritis and stroke risk: a systematic review and meta-analysis
Using deep learning to predict tyrosinase inhibitors for treating hyperpigmentation disorders
Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
Computational screening of natural inhibitors against Plasmodium falciparum kinases: Toward novel antimalarial therapies
Integration of structure-based drug design approach to generate novel thymidine kinase inhibitor against
A retrospective investigation of the platelet-to-lymphocyte ratio as a potential indicator in early rheumatoid arthritis
Topical Nanoemulsion of Leflunomide for Rheumatoid Arthritis: Formulation, Optimization and Ex Vivo Assessment
Gene expression profiles of Protein tyrosine phosphatase non-receptor 22, Tumor necrosis factor receptor-associated factor 1 and Interleukin-1 beta in patients with rheumatoid arthritis and healthy controls after severe acute respiratory syndrome-associated coronavirus-2 infection or vaccination
The effectiveness of smart healthcare for patients with rheumatoid arthritis: A systematic review and meta-analysis
Comparative Analysis of the Average Recommendation Time for the Incorporation of Biological Drugs for Cancer and Rheumatoid Arthritis
New Studies of Pathogenesis of Rheumatoid Arthritis with Collagen-Induced and Collagen Antibody-Induced Arthritis Models: New Insight Involving Bacteria Flora
Rho-Associated Protein Kinase Inhibitor and Hypoxia Synergistically Enhance the Self-Renewal, Survival Rate, and Proliferation of Human Stem Cells
Acute pulmonary edema due to hypoxia during a difficult intubation in a rheumatoid arthritis patient
[Retracted] Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis
Retracted: Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis
Investigation of the Frequency of CRP Gene Polymorphism in Rheumatoid Arthritis and Associations with CRP Level and Clinical Involvements of the Disease
Mesenchymal Stem Cell Therapy in Osteoarthritis and Rheumatoid Arthritis: A Systematic Review of Exosomal microRNAs
Gaps in Chronic Disease Monitoring during the Pandemic Period: A Case of Rheumatoid Arthritis with Functional Impairment
JNK inhibitors: is there a future?